3,6-diethylcatechol | 30203-42-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 3,6-diethylcatechol
• 英文别名: 3,6-Diaethyl-brenzkatechin；3,6-Diethylbenzene-1,2-diol
• CAS: 30203-42-0
• 化学式: C₁₀H₁₄O₂
• 分子量: 166.22
• InChiKey: HUJDVJNPBVXHHG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3,10-dihydroxy-3,5,8,10-tetraethyltricyclo[6.2.2.0^2,7]dodeca-5,11-diene-4,9-dione 在 air 作用下， 以 甲苯 为溶剂， 反应 16.0h， 以50.8 mg的产率得到3,6-diethylcatechol
  参考文献：
  名称：

  通过 o-Quinol 二聚体的 Retro Diels-Alder 反应从 o-Quinols 重排为多取代的邻苯二酚

  摘要：

  自 1958 年以来，邻羟基苯酚的 1,2-重排一直是一个长期未解决的问题。尽管重排预计可用于儿茶酚衍生物的合成，但它受到许多竞争反应的阻碍，并且尚未开发为有用的方法。在这里，我们通过第一次系统彻底的调查成功地解决了这个问题，将 1,2-重排确定为与邻羟基苯酚二聚体的逆 Diels-Alder 反应的级联反应。这是合成用作生物活性化合物和材料分子的合成构件的取代儿茶酚的有用策略。○- 喹啉二聚体是通过改进取代酚的氧化羟基化反应合成的，然后是自发的 Diels-Alder 反应。然后二聚体经历逆Diels-Alder反应以再生邻羟基喹啉，然后在中性加热条件下在适当的温度下根据迁移取代基进行1,2-重排，以良好的产率提供取代的儿茶酚。通过控制反应温度，可以最大限度地减少竞争反应，例如取代基的消除或 α-酮醇重排。

  DOI：

  10.1246/bcsj.20220025

文献信息

• BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR RENAL THERAPY
  申请人：Whiteford Jeffery A.

  公开号：US20100004218A1

  公开（公告）日：2010-01-07

  A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to control fluid and/or waste levels.

  描述了一种药用活性剂、一种药用活性剂载体及其使用方法。在一些实施例中，系统可能包括一种组合物。该组合物可能包括一个或多个桥联多环化合物。至少一个桥联多环化合物可能包括至少两个环状基团，并且至少两种药用活性剂可能与桥联多环化合物相关联。在一些实施例中，一个或多个桥联多环化合物可以被用于控制主体的液体和/或废物水平。
• BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR CONTROLLING CHOLESTEROL LEVELS
  申请人：Whiteford Jeffery A.

  公开号：US20100016270A1

  公开（公告）日：2010-01-21

  A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to improve cardiac and/or cardiovascular health. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to control cholesterol levels.

  本文描述了一种药理活性剂、药理活性剂载体及其使用方法。在某些实施例中，该系统可能包括一种组合物。该组合物可能包括一个或多个桥接多环化合物。其中至少一个桥接多环化合物可能包括至少两个环状基团，并且至少有两种药理活性剂可能与桥接多环化合物相关联。在某些实施例中，可以向受试者施用一个或多个桥接多环化合物以改善心脏和/或心血管健康。在某些实施例中，可以向受试者施用一个或多个桥接多环化合物以控制胆固醇水平。
• Soluble late transition metal catalysts for olefin oligomerizations III
  申请人：Zhao Baiyi

  公开号：US20060036049A1

  公开（公告）日：2006-02-16

  A series of soluble α-diimine late transition metal catalysts has been invented comprising a substituted or unsubstituted catecholate ligand. The catalysts demonstrate high activity and selectivity for linear α-olefins. As such, these catalysts conveniently oligomerize ethylene. Typical activators as known to those of ordinary skill in the art are used to activate these transition metal catalysts. These catalysts can be used in a supported or unsupported form.

  一系列可溶性的α-二亚胺后过渡金属催化剂已经被发明，其中包括取代或未取代的邻苯二酚配体。这些催化剂表现出高活性和线性α-烯烃的高选择性。因此，这些催化剂方便地可以使乙烯寡聚化。通常的活化剂，如对于普通技术人员而言是已知的，被用来激活这些过渡金属催化剂。这些催化剂可以以支持或不支持的形式使用。
• SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III
  申请人：ExxonMobil Chemical Patents Inc.

  公开号：EP1620447A1

  公开（公告）日：2006-02-01
• Methods and systems for coating an oral surface
  申请人：Whiteford A. Jeffery

  公开号：US20070202342A1

  公开（公告）日：2007-08-30

  An antimicrobial coating system and method are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two of the cyclic groups may include quaternary ammonium moieties. In some embodiments, a method may include applying an antimicrobial coating to an oral surface, a surface of a construction substrate, a surface of a marine substrate, a surface of a medical device, or a surface of a personal care device. The protective coating may be antimicrobial. A protective coating may include antimicrobial bridged polycyclic compounds. Bridged polycyclic compounds may include quaternary ammonium compounds. Bridged polycyclic compounds based coating systems may impart self-cleaning properties to a surface (e.g., a tooth surface).